TY - JOUR
T1 - Association of income level with kidney disease severity and progression among children and adolescents with CKD
T2 - A report from the chronic kidney disease in children (CKiD) study
AU - Hidalgo, Guillermo
AU - Ng, Derek K.
AU - Moxey-Mims, Marva
AU - Minnick, Maria Lourdes
AU - Blydt-Hansen, Tom
AU - Warady, Bradley A.
AU - Furth, Susan L.
N1 - Funding Information:
Support: The CKiD Study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Dr Moxey-Mims serves as the NIDDK project officer on the steering committee. The study received additional funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart, Lung and Blood Institute . Grant numbers: U01-DK-66143 , U01-DK-66174 , U01-DK-82194 , and U01-DK-66116 .
PY - 2013/12
Y1 - 2013/12
N2 - Background Among adults, lower socioeconomic status (SES) is a risk factor for chronic kidney disease (CKD), progression to end-stage renal disease, and poor health outcomes; but its impact on young people with CKD is not established. Study Design Prospective cohort study. Settings & Participants 572 children and adolescents aged 1-16 years with mild to moderate CKD residing in the United States and Canada who were enrolled in the Chronic Kidney Disease in Children (CKiD) Study. Predictor Self-reported annual household income category as a proxy measure for SES: ≥$75,000 (high income), $30,000 to <$75,000 (middle income) and <$30,000 (low income). Outcomes & Measurements Clinical characteristics and CKD severity at baseline (glomerular filtration rate [GFR] and comorbid conditions related to disease severity and management) and longitudinally (GFR decline and changes in blood pressure z scores and height z scores per year). Results At baseline, low and middle household incomes, compared to high income, were associated with minority race (39% and 20% vs 7%), lower maternal education (28% and 5% vs 1%), abnormal birth history (34% and 32% vs 21%), and having at least one clinical comorbid condition (66% and 64% vs 55%). Baseline median GFRs were similar across income categories (43-45 mL/min/1.73 m2). After adjusting for baseline differences, average GFR declines per year for the low-, middle-, and high-income categories were -2.3%, -2.7%, and -1.9%, respectively, and were not statistically significantly different among groups. Blood pressure control tended to improve in all groups (z score, -0.10 to -0.04) but higher income was associated with a faster improvement. Each group showed similar deficits in height at baseline. Height deficits diminished over time for participants from high-income families, but not among those from low-income families (z scores for height per year, 0.05 and -0.004, respectively; P = 0.03 for comparison of high and low income). Limitations Income is an imperfect measure for SES; CKiD participants are not representative of children and adolescents with CKD who are uninsured or not receiving care; statistical power to detect associations by income level is limited. Conclusions GFR decline was similar across income groups but better improvement in BP was observed among those with high income. Children and adolescents with CKD from lower income households are at higher risk of impaired growth.
AB - Background Among adults, lower socioeconomic status (SES) is a risk factor for chronic kidney disease (CKD), progression to end-stage renal disease, and poor health outcomes; but its impact on young people with CKD is not established. Study Design Prospective cohort study. Settings & Participants 572 children and adolescents aged 1-16 years with mild to moderate CKD residing in the United States and Canada who were enrolled in the Chronic Kidney Disease in Children (CKiD) Study. Predictor Self-reported annual household income category as a proxy measure for SES: ≥$75,000 (high income), $30,000 to <$75,000 (middle income) and <$30,000 (low income). Outcomes & Measurements Clinical characteristics and CKD severity at baseline (glomerular filtration rate [GFR] and comorbid conditions related to disease severity and management) and longitudinally (GFR decline and changes in blood pressure z scores and height z scores per year). Results At baseline, low and middle household incomes, compared to high income, were associated with minority race (39% and 20% vs 7%), lower maternal education (28% and 5% vs 1%), abnormal birth history (34% and 32% vs 21%), and having at least one clinical comorbid condition (66% and 64% vs 55%). Baseline median GFRs were similar across income categories (43-45 mL/min/1.73 m2). After adjusting for baseline differences, average GFR declines per year for the low-, middle-, and high-income categories were -2.3%, -2.7%, and -1.9%, respectively, and were not statistically significantly different among groups. Blood pressure control tended to improve in all groups (z score, -0.10 to -0.04) but higher income was associated with a faster improvement. Each group showed similar deficits in height at baseline. Height deficits diminished over time for participants from high-income families, but not among those from low-income families (z scores for height per year, 0.05 and -0.004, respectively; P = 0.03 for comparison of high and low income). Limitations Income is an imperfect measure for SES; CKiD participants are not representative of children and adolescents with CKD who are uninsured or not receiving care; statistical power to detect associations by income level is limited. Conclusions GFR decline was similar across income groups but better improvement in BP was observed among those with high income. Children and adolescents with CKD from lower income households are at higher risk of impaired growth.
KW - Socioeconomic status
KW - adolescents
KW - children
KW - chronic kidney disease
KW - growth
KW - progression
UR - http://www.scopus.com/inward/record.url?scp=84888325461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888325461&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2013.06.013
DO - 10.1053/j.ajkd.2013.06.013
M3 - Article
C2 - 23932090
AN - SCOPUS:84888325461
SN - 0272-6386
VL - 62
SP - 1087
EP - 1094
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 6
ER -